Related Experiment Video
Updated: Feb 24, 2026

One-anastomosis Gastric Bypass OAGB in Rats
Published on: November 10, 2018
The natural history of perforated marginal ulcers after gastric bypass surgery
Maria S Altieri1, Aurora Pryor2, Jie Yang3
1Division of Bariatric, Foregut and Advanced Gastrointestinal Surgery, Department of Surgery, Stony Brook University Medical Center, 100 Nichols Road, HSC T19, Stony Brook, NY, 11794, USA. maria.altieri@stonybrookmedicine.edu.
Introduction:
Although perforated marginal ulcers (pMU) following Roux-en-Y Gastric Bypass (RYGB) represent a surgical emergency, the epidemiology and outcome of this condition is not well understood. The purpose of this study was to evaluate incidence of pMU following RYGB and assess the natural history of this complication.
Methods:
The SPARCS administrative database was used to identify patients undergoing RYGB between 2005 and 2010. With the use of a unique identifier, we followed patients up to 2014 for subsequent admission and re-intervention (repair or revision) for perforated MU. Groups were compared using Chi square tests with exact p values based on Monte Carlo simulation, t test with unequal variances, and the Wilcoxon rank-sum test when appropriate.
Results:
We identified 35,080 RYGB patients; 292 patients (0.83%) developed pMU 937 (443-1546) days following RYGB [Median (Q1-Q3)]. Among these 292 patients, tobacco use was present in one-third of patients. Repair of the perforation was performed in 115 patients, while anastomotic revision was reported in 64. Patients who underwent revision were more likely to have respiratory complications. Hospital length of stay was significantly longer for patients managed with RYGB revision (Median, Q1-Q3:7, 5-14, vs 6, 4-7, days, p = 0.001). Recurrence of marginal ulcer was common after either intervention (26.09% for repair and 29.69% for revision, p = 0.726).
Conclusion:
Following RYGB, the incidence of pMU is small. Anastomotic revision for pMU is associated with prolonged length of stay compared to repair alone. Importantly, recurrence after intervention of pMU is common, suggesting possible value of a routine surveillance program for patients following pMU.
Insights
Perforated marginal ulcers (pMU) after Roux-en-Y Gastric Bypass (RYGB) are rare but recurrence is common. Anastomotic revision for pMU leads to longer hospital stays than repair, with similar recurrence rates.
Area of Science:
- Gastroenterology
- Bariatric Surgery
- Surgical Complications
Background:
- Perforated marginal ulcers (pMU) are a serious complication following Roux-en-Y Gastric Bypass (RYGB).
- The epidemiology and long-term outcomes of pMU after RYGB are not well-established.
- Understanding these outcomes is crucial for managing this surgical emergency.
Purpose of the Study:
- To determine the incidence of pMU in patients who underwent RYGB.
- To assess the natural history and outcomes of pMU following RYGB.
- To evaluate the effectiveness of different management strategies for pMU.
Main Methods:
- Utilized the SPARCS administrative database to identify RYGB patients (2005-2010).
- Tracked patients through 2014 for admissions related to pMU and subsequent interventions.
- Employed statistical tests including Chi-square, t-test, and Wilcoxon rank-sum for group comparisons.
Main Results:
- Identified 35,080 RYGB patients; 0.83% (292) developed pMU.
- Tobacco use was noted in one-third of patients with pMU.
- Anastomotic revision (64 patients) was linked to longer hospital stays and more respiratory complications compared to repair (115 patients).
- Recurrence rates were high and similar for both repair (26.09%) and revision (29.69%).
Conclusions:
- The incidence of pMU following RYGB is low.
- Anastomotic revision for pMU is associated with increased hospital length of stay.
- High recurrence rates suggest the potential benefit of routine surveillance programs for patients post-pMU intervention.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peripheral Artery Disease V: Postoperative Nursing Management
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

